Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Please Try Again {{ error }}

Send my password

SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.

Petrolympic Ltd V.PCQ

Alternate Symbol(s):  PCQRF

Petrolympic Ltd. is a Canada-based gold and lithium mining company. The Company is focused on its lithium exploration assets in the James Bay region, Basserode and Fourniere in Abitibi region as well as its gold exploration assets at Vauquelin and Rayon d’Or in the Val d’Or region, all in the Province of Quebec, Canada. The Li-1 and Li-2 Properties are located in the James Bay - Eeyou Itschee area, approximately 125 kilometers (km) north of the town of Chibougamau. The Basserode and Fourniere Lithium Properties are located in the Abitibi-Temiscamingue region, southwest of the Val d’Or mining camp, Quebec. Its Belcourt Property consists of 125 claims distributed in four blocks (Belcourt North, South, Central and West blocks), all proximal to one another and covering a total of 5,479 hectares. Its Rayon d’Or and Vauquelin Gold Properties are located within a gold mining camp in Northwestern Quebec, in the center of Vauquelin township (NTS 32C03), over 40 km east of the town of Val d’Or.


TSXV:PCQ - Post by User

Post by Rebeccaon Jun 03, 2022 4:19am
76 Views
Post# 34728695

FSD Will Proceed with Phase2 of FSD-201 Soon After Clearance

FSD Will Proceed with Phase2 of FSD-201 Soon After Clearance



FSD Pharma ready to proceed with Phase 2 clinical trial of FSD-201 as soon as it gets clearance
 
FSD Pharma Inc CEO Anthony Durkacz told Proactive that the company is ready to proceed with the planned Phase 2 clinical trial of its FSD-201 drug candidate as soon as it gets the go-ahead from the US Food and Drug Administration and Health Canada. That's after submitting Investigational New Drug (IND) applications to the two bodies this week. Armed with cash of about $50 million following the $16.4 million disposal of its former cannabis production facility in Ontario, Durkacz said FSD is also moving full-steam ahead on its two other drug candidates and may look for other opportunities. A special dividend may also be on the cards, he added.



<< Previous
Bullboard Posts
Next >>